C
Cboe Global Markets, Inc.
CBOE · Financial Services
Q4 FY2025
Earning ended Dec 31, 2025Report generated Mar 15, 2026
The Volatility Toll Booth the Market Keeps Mispricing as Cyclical
The market's persistent habit of valuing Cboe on near-term volume multiples is systematically wrong now that the data and access revenue layer has crossed a threshold where it materially stabilizes earnings through low-volatility periods — the business is structurally less cyclical than the valuation framework assumes. Meanwhile, the 0DTE phenomenon didn't create new competitors; it concentrated new volume into Cboe's existing franchise through the same liquidity gravity that has always made index options a winner-take-most market.
Flowly Score
Apr 16 Close
+8%$309.38
Fair Value
$335.00
74
Strongat $309.38
Business Strength8/10
Cboe owns the global vocabulary of volatility — exclusive SPX and VIX licenses are effectively a cornered resource that no competitor can replicate, and the self-reinforcing liquidity network in index options deepens that moat every year. The 2023 CEO departure is a genuine governance mark that keeps this from a 9.
Financial Resilience8/10
A business where capex is nearly irrelevant and operating cash flow tracks earnings with clockwork consistency is about as resilient as financial infrastructure gets — the 0.9x leverage ratio and substantial cash buffer mean this franchise can absorb a multi-year volume drought without structural damage. The 2022 earnings trough proved the point: the cash engine never stopped even when reported profits collapsed.
Growth & Trajectory7/10
The 0DTE options explosion is a structural behavioral shift in how market participants manage daily risk, not a volatility spike that reverses — and Cboe's SPX complex is the only credible venue for it, so volume growth is compounding on top of an already entrenched franchise. The DataVantage subscription layer growing almost entirely from new units rather than price increases signals durable demand expansion, not pricing exhaustion.
Valuation6/10at $289.90
The business is objectively better — higher ROIC, more recurring revenue, deeper network effects — than it was when it commanded materially higher multiples, yet the stock sits near a five-year valuation floor; that's a combination that usually resolves upward, not sideways. The incomplete FCF reporting creates an optical distortion that punishes the stock in screens, creating a narrow window where quality and price align.
Risk6/10
The SPX and VIX licensing arrangement is the keystone of the entire franchise, and its terms are not public — a renegotiation or broadening of that license would be an existential event the market is not pricing at all. Regulatory scrutiny of 0DTE options from the SEC and CFTC is a live and specific threat, not an abstract one, and a structural volume cap on short-dated expirations would surgically remove the highest-growth engine in the business.
The investment case rests on a specific mismatch: a franchise that is measurably getting stronger — ROIC compounding upward, recurring revenue mix expanding, global derivatives adoption still in its early innings — while the market prices it as though it were a mature, cyclical toll road with no growth premium warranted. The current multiple is near a five-year low at precisely the moment operating margins are near five-year highs. That divergence between quality trajectory and applied valuation is the entire thesis, and it doesn't require heroic assumptions to resolve in shareholders' favor. The direction of this business is toward greater durability, not less. The quiet but important evolution is the DataVantage and access fees segment, which operates almost entirely independently of whether markets are volatile or calm. Every institutional desk that builds workflows around Cboe data, every structured product linked to the VIX, every prime broker whose margining framework incorporates SPX contract specifications — these are switching costs that accumulate silently while the market focuses on quarterly contract volume prints. The international buildout of clearing infrastructure in Europe adds network nodes that make the platform more valuable to global participants even as management sensibly exits subscale geographies. The single risk that warrants the most honest attention is regulatory action on zero-day options specifically. This is not a generic 'regulatory risk' placeholder — the SEC and CFTC have named short-dated options as a systemic concern in formal communications, and a hard structural limit on expiration frequency or notional size would not just slow growth, it would reverse the earnings trajectory that justifies owning the stock at any premium. That regulatory outcome is unlikely but not remote, and it is the one scenario where the moat provides no protection whatsoever.